Body of Knowledge
The scope of the scientific field of Doctoral Study Program in Pharmacy is closely related to the Undergraduate Study Program in Pharmacy, both the Pharmaceutical Science and Technology and Clinical and Community Pharmacy study program, and Master’s program. Inline science in the doctoral program is a further development of the knowledge obtained at the undergraduate and master’s levels in Pharmacy. Body of knowledge of Doctoral Study Program in Pharmacy is multidisciplinary science in relation to drugs, cosmetics, health supplement products, medical devices, and other pharmaceutical preparations, including applied sciences originating from biology (biological/life sciences), chemistry, physics, and human behavioral sciences. Science in the field of medicinal chemistry starts from synthesis, analysis and characterization, discovery and development of new compounds to cover the fields of analytical pharmaceutical chemistry, food analysis and safety, and medicinal chemistry. Sciences related to pharmaceutics include pharmaceutical technology, biopharmaceuticals, pharmacokinetics and pharmaceutical biotechnology. Sciences related to drugs derived from natural materials include the fields of phytochemistry, standardization of natural materials, structural elucidation of compounds of natural ingredients, and biotechnology of medicinal plants. Pharmacology-toxicology sciences include knowledge of pharmacology, toxicology, pharmacotherapy, clinical pharmacy, and drug interactions.
Challenges
The era of globalization has a major impact on the future life of the world society, including Indonesia. The impact can be felt in various fields. The development of drugs and other pharmaceutical preparations, including fields, is greatly influenced by the opening of a wider trading faucet. The readiness of high-quality resources with the highest competence according to Indonesian National Qualifications Framework (Kerangka Kualifikasi Nasional Indonesia, KKNI) is an avoidable necessity, so that it becomes a serious challenge for Doctoral Program in Pharmacy in preparing these resources while at the same time producing research products that can be widely utilized. Science and technology in the field of pharmacy and medicinal products in order to improve public health at the global level is growing very rapidly. This development is marked by the increasing variety of pharmaceutical products and services. The trend of increasing research and development in the global pharmaceutical industries and several of them in Indonesian will have an impact on the broad segment related to manufacturing and provide a clear message to universities that provide education and research to seriously improve the quality of education and research that can answer various problems that exist in all relevant stakeholders. The development of existing drugs and the discovery of new drugs have shown that scientific knowledge is of fundamental value in achieving drug discovery and development. Until now, very little research at the universities is related to research and development in the industrial field. This phenomenon will be a challenge for the School of Pharmacy ITB to work together with stakeholders to develop various solutions to overcome problems related to drugs and health through research activities. The pharmaceutical industry’s need for quality human resources has increased sharply, especially those related to pharmaceutical science and technology. Research conducted at the Doctoral program in Pharmacy, where most of the study period is used for research, has a major role in the development of various aspects related to drugs and other pharmaceutical preparations.
Accreditation or Reference Curriculum Standard
Accreditation will be submitted to the National Accreditation Board (Badan Akreditasi Nasional, BAN) as a national accreditation agency in Indonesia
- Strategic Plan of the School of Pharmacy ITB 2011-2015
- Government Regulation Number 66 Year 2010 concerning Amendments to PP. 17 Year 2010 concerning the Management and Implementation of Education
- ITB Curriculum Preparation Guidelines for 2013-2018 in 2012
- School of Pharmacy ITB, Curriculum Evaluation Workshop 2012, December 2011, SF, Bandung
- School of Pharmacy ITB, Curriculum Preparation Workshop 2013, December 2012, SF, Bandung
- Academic Senate of ITB, Academic Senate of ITB’s Decree Number: XX/SK/K01-SA/2012, concerning “CURRICULUM GUIDELINES 2013”
- Accreditation Council for Pharmacy Education, 2007, Accreditation Standards for Continuing Pharmacy Education, Accreditation Council for Pharmacy Education, Chicago, Illinois
References
- Presidential Decree Number 8 Year 2012 concerning the KKNI
- Law of the Republic of Indonesia Number 36 Year 2009 concerning Health
- Law of the Republic of Indonesia Number 12 Year 2012 concerning Higher Education
- Government Regulation Number 51 Year 2009 concerning Pharmaceutical Work
- Government Regulation Number 66 Year 2010 concerning Amendments to PP. 17 Year 2010 concerning the Management and Implementation of Education
- Strategic Plan of the School of Pharmacy ITB 2011-2015
- ITB Curriculum Preparation Guidelines for 2013-2018 in 2012
- School of Pharmacy ITB, Curriculum Evaluation Workshop 2012, December 2011, SF, Bandung
- SekolahFarmasi ITB, Workshop PenyusunanKurikulum 2013, Desember 2012, SF, Bandung
- Academic Senate of ITB, Academic Senate of ITB’s Decree Number: XX/SK/K01-SA/2012, concerning “CURRICULUM GUIDELINES 2013”
- Accreditation Council for Pharmacy Education, 2007, Accreditation Standards for Continuing Pharmacy Education, Accreditation Council for Pharmacy Education, Chicago, Illinois
- International Pharmaceutical Federation (FIP), 2010, Global Competency Framework Draft Version | August 2010
- 5th AASP Conference in Bandung, 2011, Indonesia
- Asia Pacific Pharmacy Education Workshop, 20-21 November, 2012
- Directive 2005/36/ec of the European Parliament and of the Council of 7 September 2005 on the Recognition of Professional Qualifications
List of School of Pharmacy ITB Promoters
GROUP OF EXPERTISE : Pharmacy Biology
Elfahmi, Dr., Apt.
Irda Fidrianny, Prof., Dr., Apt.
Muhamad Insanu, Dr. M.Si., Apt.
Sukrasno, Prof., Dr., Apt.
Scientific Group Pharmacochemistry
Daryono Hadi Tjahjono, Prof., Dr., Apt.
Marlia Singgih Wibowo, Ph.D., Apt.
Rahmana Emran Kartasasmita, Dr. rer. nat., Apt.
Sophi Damayanti, Dr. rer. nat., Apt.
Dr. apt. Ilma Nugrahani
KK Farmakologi-Farmasi Klinik
I Ketut Adnyana, Prof., Dr., Apt.
Kusnandar Anggadiredja, Dr., Apt.
Lia Amalia, Dr., Apt.
Maria Immaculata Iwo, Dr., Apt.
Neng Fisheri Kurniati, Dr., Apt.
GROUP OF EXPERTISE : Pharmaceutics
Lucy Nurhayati Sasongko, Dr., Apt.
Diky Mudhakir, Dr., Apt.
Heni Rachmawati, Prof. Dr., Apt.
Rachmat Mauludin, Dr., Apt.
Sukmadjaja Asyarie, Prof., Dr., Apt.
Sundani Nurono Suwandhi, Prof., Dr., Apt.
Tri Suciati, Dr., Apt.
Yeyet Cahyati Sumirtapura, Prof., Dr., Apt.
Vision of Study Program
Being the organizer of Doctoral Program in Pharmacy that is considered at the international level and producing program outcomes that are able to contribute to improving the quality of life and public health status.
Mission of Study Program
- Organizing doctoral program education that plays a major role in the development of science and technology in the pharmaceutical sector and its use in the advancement of science and development of pharmaceutical products.
- Organizing doctoral program education with an innovative, competitive, and sustainable research focus.
- Becoming a doctoral education program in Pharmacy that can establish effective collaboration with various domestic and foreign stakeholders.
Educational Purposes
The Doctoral Program in Pharmacy aims at:
- Producing graduates who have (skill of thinking), high integrity, and analytical and synthesis skills to find comprehensive solutions to various problems in the pharmaceutical field.
- Producing graduates who are able to carry out the latest scientific research, have novelty and originality values in the pharmaceutical field, and are able to play a role in the development of science and pharmaceutical products.
- Producing graduates who are able to work independently and in groupsteam workcollaborate with various related parties, and provide scientific benefits for improving the quality of life and public health status, especially the Indonesian nation.
- Producing graduates who are able to disseminate and or publish the results of dissertation research in national and international scientific forums and or journals, or in the form of patents, so that the results can be utilized for the wider community.
Indonesian National Qualifications Framework (Kerangka Kualifikasi Nasional Indonesia, KKNI)
- Being able to develop new knowledge, technology, and or art in the scientific field or professional practice through research, to produce creative, original, and tested works
- Being able to solve problems of science, technology, and or art in the scientific field through inter, multi or transdisciplinary approaches.
- Being able to manage, lead, and improve research and development that is beneficial for science and the benefit of mankind, and is able to gain national and international recognition.
Program of Learning Outcomes (PLO)
- Being able to demonstrate (skill of thinking), analysis and synthesis in pharmaceutical sciences.
- Being able to develop new knowledge and technology so as to produce creative, original, and tested works in pharmaceutical science.
- Being able to solve science and technology problems in the field of pharmacy through inter, multi or transdisciplinary approaches.
- Being able to design and conduct creative, original, and tested research in the pharmaceutical field.
- Being able to manage and lead research effectively.
- Being able to work together effectively, both individually and in groups.
- Being able to communicate the results of thoughts and research both spoken and written, which are recognized at the national and international level.
- Having professionalism and high integrity.
Keterkaitan antara KKNI dan TUJUAN PRODI S3 dengan PLO
|
KKNI |
TUJUAN Prodi S3 | PLO |
|
1 |
1,2 |
1,2,4 |
|
2 |
3 |
3 |
|
3 |
4 |
4,5,6,7 |
|
1 |
8 |
Keterkaitan antara Mata kuliah dengan PLO
| NO | KODE KULIAH | NAMA KULIAH | SKS | PLO |
| 1 | FA 7001 | Falsafah Ilmu Pengetahuan | 2 | 1,2,8 |
| 2 | FA 5002 | Metodologi penelitian | 3 | 1,3, 5,8 |
| 3 | FA 7092 | Ujian kualifikasi | 2 | 1,2,3,4,7,8 |
| 4 | FA XXXX | Pilihan 1 | 2 | 1 |
| 5 | FA XXXX | Piluhan 2 | 2 | 1 |
| 6 | FA XXXX | Pilihan 3 | 2 | 1 |
| 7 | FA 7091 | Penyusunan proposal | 3 | 1,4 |
| 8 | FA 8091 | Penelitian & Seminar Kemajuan 1 | 5 | 1-8 |
| 9 | FA 8092 | Penelitian & Seminar Kemajuan 2 | 5 | 1-8 |
| 10 | FA 9091 | Penelitian & Seminar Kemajuan 3 | 5 | 1-8 |
| 11 | FA 9092 | Penelitian & Seminar Kemajuan 4 | 5 | 1-8 |
| 12 | FA 9093 | Ujian Disertasi | 3 | 1-8 |
Keterkaitan antara PLO dengan Mata kuliah
To be able to take part in the Doctoral Study Program in Pharmacy properly, prospective students need to have an educational background equivalent to a Master’s in the fields of pharmacy. Those with Master’s backgrounds such as Chemistry, Biology, Medicine, Dentistry, Food Technology, Chemical Engineering, and other relevant fields can be accepted, as long as they pass the interview and meet the TPA and TOEFL requirements. However, those with Master’s degree in other relevant fields must take additional courses in accordance with their choices and other courses determined by KPPS.
Pharmacy graduates with excellent academic achievements are allowed to directly follow the Doctoral Program without passing the Master’s Program (excellent doctoral program). Participants of the excellent doctoral program are selected very strictly, which allows them to complete their doctoral studies in 3 years. If at the qualification stage they are deemed unfit to continue until the doctoral program is completed, the person concerned will be terminated until Master’s Degree.
Kurikulum Doktor
